$4.98
-0.05[-0.99%]
Last update: 9:07AM Get Real Time Here
Aurinia Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aurinia Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/02/2024 | AM | AUPH | Q1 | -$0.18 | -$0.14 | — | — | $34.41M | $47.45M | — | — | Get Alert |
02/15/2024 | AM | AUPH | Q4 | -$0.18 | -$0.16 | -$0.19 | -18.75% | $28.43M | $44.45M | $45.09M | 1.45% | Get Alert |
11/02/2023 | AM | AUPH | Q3 | -$0.06 | -$0.17 | -$0.09 | 47.06% | $55.78M | $38.50M | $54.52M | 41.60% | Get Alert |
08/03/2023 | AM | AUPH | Q2 | -$0.25 | -$0.20 | -$0.08 | 60.00% | $28.19M | $36.37M | $41.49M | 14.09% | Get Alert |
05/04/2023 | AM | AUPH | Q1 | -$0.27 | -$0.22 | -$0.18 | 18.18% | $21.63M | $27.87M | $34.41M | 23.46% | Get Alert |
02/28/2023 | AM | AUPH | Q4 | -$0.25 | -$0.27 | -$0.18 | 33.33% | $23.40M | $27.78M | $28.43M | 2.36% | Get Alert |
11/03/2022 | AM | AUPH | Q3 | -$0.39 | -$0.17 | -$0.06 | 64.71% | $14.67M | $36.18M | $55.78M | 54.17% | Get Alert |
08/04/2022 | AM | AUPH | Q2 | -$0.37 | -$0.22 | -$0.25 | -13.64% | $6.62M | $27.14M | $28.19M | 3.87% | Get Alert |
05/10/2022 | AM | AUPH | Q1 | -$0.40 | -$0.27 | -$0.27 | 0.00% | $914.00K | $19.76M | $21.63M | 9.44% | Get Alert |
02/28/2022 | AM | AUPH | Q4 | -$0.06 | — | -$0.25 | — | $50.03M | — | $23.40M | — | Get Alert |
11/03/2021 | AM | AUPH | Q3 | -$0.28 | -$0.33 | -$0.39 | -18.18% | $29.00K | $13.88M | $14.67M | 5.67% | Get Alert |
08/05/2021 | PM | AUPH | Q2 | -$0.26 | -$0.14 | -$0.37 | -164.29% | $29.00K | $40.00K | $6.62M | 16450.00% | Get Alert |
05/06/2021 | PM | AUPH | Q1 | -$0.23 | -$0.14 | -$0.40 | -185.71% | $30.00K | $40.00K | $914.00K | 2185.00% | Get Alert |
02/24/2021 | PM | AUPH | Q4 | -$0.29 | -$0.14 | -$0.05 | 64.29% | $29.00K | $40.00K | $50.03M | 124975.00% | Get Alert |
11/10/2020 | PM | AUPH | Q3 | -$0.21 | -$0.15 | -$0.28 | -86.67% | $230.00K | $50.00K | $29.00K | -42.00% | Get Alert |
08/11/2020 | PM | AUPH | Q2 | -$0.17 | -$0.14 | -$0.26 | -85.71% | $29.00K | $40.00K | $29.00K | -27.50% | Get Alert |
05/14/2020 | PM | AUPH | Q1 | -$0.14 | -$0.15 | -$0.15 | 0.00% | $30.00K | $50.00K | $30.00K | -40.00% | Get Alert |
03/05/2020 | PM | AUPH | Q4 | -$0.17 | -$0.15 | -$0.29 | -93.33% | $29.00K | $50.00K | $29.00K | -42.00% | Get Alert |
11/14/2019 | PM | AUPH | Q3 | -$0.21 | -$0.15 | -$0.21 | -40.00% | $375.00K | $50.00K | $230.00K | 360.00% | Get Alert |
Aurinia Pharmaceuticals (AUPH) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 15, 2024 for Q4.
The Actual EPS was $-0.19, which missed the estimate of $-0.16.
The Actual Revenue was $45.1M, which beat the estimate of $44.5M.
Browse earnings estimates, EPS, and revenue on all stocks.